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Abstract

Athletics is constantly changing, and athletes are continually getting bigger, faster, and
stronger. At the same time, biomedical technology and innovation is rapidly developing.
New methods of injury recovery, genetic enhancement, and prosthetic assistance are
being assimilated into the athletic world. The up and coming athlete needs to be aware of
all of the usable information around them. This project is an accumulation of some of the
cutting edge advancements in those fields. Platelet Rich Plasma Injections, Frequency
Specific Microcurrent Treatment, and Silk Polymer Anterior Cruciate Ligament
Replacement are innovative new ways to treat common sports injuries. Performance
enhancement has increased to new feats of gene doping Erythropoietin hormone, Insulinlike Growth Factor 1 hormone, and orally consuming PPAR-delta modulator compound.
The Ossur Flex-Foot Cheetah and Ottobock Genium prosthetics have allowed athletes to
compete at the highest level possible despite traumatic injury or birth defects. The design
aspect of this project is a prototype for a website in the form of a local program, created
in Java, with a graphical user interface. This prototype allows the user to make selections
of their sport of interest and their desired field of study, and then outputs the information
of the newest innovation applicable.
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Biomedical Advancements in Injury Recovery, Performance Enhancement, and
Mechanical Assistance Applied to Athletics
Introduction
The entirety of athletics has rapidly evolved over the years. Within the last
century athletes have progressed physically at an alarming rate. The 100 meter dash
record has changed from 10.8 seconds in 1891 to 9.58 seconds in 2009 (100M Men,
2012). In Major League Baseball, the career homerun record has increased from 714 by
Babe Ruth in 1935, to 755 by Hank Aaron in 1976, and then to 762 by Barry Bonds in
2007 (Overall Baseball Leaders, 2011). In the recent summer Olympic Games of 2012,
Oscar Pistorius of South Africa was the first Paralympic athlete to compete in the
Olympic Games. The world watched a man, who at a previous time would have never
dreamed to compete for Olympic gold, run with prosthetic assistance on the biggest stage
of his life. So, not only has the physiological limitations of athletes changed, but the
technological assistance of athletes has changed as well. With the continuing
advancements in technology and biomedical breakthroughs, it is hard to determine where
the limitations of future athletes will end up.
In a world where athletics and technology is consistently changing and advancing,
how does the athlete of the future stay up to date about the advantages at his or her
disposal? Furthermore, how does the future athlete stay informed about the pitfalls of
illegal enhancement surrounding them? Barry Bonds, Alex Rodrigues, Shawne
Merriman, Bill Romanowski, Marion Jones, Ben Johnson, Fernando Vargas, and Shane
Mosley are all known for breaking records and pushing the limits of their respective
sport, however; they are also known for their illegal use of performance enhancing

BIOMEDICAL ADVANCEMENTS

7

methodologies. Whether it is for rapid injury recovery or just to get a leg up on the
competition, performance enhancement and medicinal recovery can be dangerous and it
is up to the athlete to become informed on legality and safety. Information is power when
the injured athlete is searching for the fastest recovery mechanism during a fasted paced
season. And amidst the wreckage of technological controversy in sports, where does the
athlete in need of prosthetic assistance go to find help? An information hub for athletes is
in desperate need. Athletes need to be informed about the biomedical technology at their
fingertips, and they need to be warned about the possible dangers it can have on their
careers.
In order to inform the future athlete about the latest recovery techniques available,
the possibly illegal enhancements on the horizon, and the newest mechanical
breakthrough in prosthetic assistance; a one stop, easy access database needs to be
created. This system needs to be designed to conform to the specific details of each
individual sport and desires of each individual athlete. The design also needs to
incorporate the media driven technological standards of the athletic environment. The
future athlete should be equipped with the knowledge to make positive decisions for their
athletic endeavors after using said system.
The intent of this project is to design a prototype of a website in the form of a
graphical user interfaced local program for the future athlete. This program will
incorporate a screening process designed to bring the athlete information detailed to their
unique sporting specifics. With a few tailored questions and a few clicks, future athletes
will have information about the latest cutting edge bioengineering repair methods for
injuries, informative guidance about the future of genetically engineered enhancements,

BIOMEDICAL ADVANCEMENTS

8

and details about advanced prosthetics for the athlete looking to continue their sporting
endeavors. Through the use of Java, this program will contain information about the
latest technology in prosthetic design, the newest developments in genetic and stem cell
physical enhancement, and some of the injury recovery mechanisms and methods new to
public use.
In theory, this site would allow the injured athlete easy access to information
about the possibly fastest recovery mechanism. This site would also inform the up and
coming athlete about the newest enhancement techniques in order to avoid ignorant
pitfalls in their athletic career. Lastly, this site would bring hope to the athlete looking for
biomedical help to continue competing.
This report will discuss research on three categories of biomedical engineering
and technology. These categories include injury repair mechanisms and methodologies,
genetic enhancement through gene doping, and mechanical assistant via prosthetic
design. The design of the Java program will be disclosed and discussed along with the
methodology and applications. Data will be collected and discussed, as athletes from
soccer, tennis, football, baseball, and track and field use the program to acquire
information. Overall, this project will seek to accumulate and distribute information for
the benefit of athletics and the future athlete.
Background/Literature
The world of sports is very demanding and extremely fast paced. During the
2012/13 NFL season, 49er quarterback Alex Smith sustained a concussion in the third
game of the season and was quickly replaced by Colin Kaepernick. Smith had four
touchdown passes, 304 yards throwing, and quarterback rating of 80% over two games,
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however; Kaepernick stepped in and took the position for the remainder of the season
even though Smith was only ineligible to play for one week (Alex Smith, 2013). What if
Alex Smith would have been able to recover more quickly? Would he have been able to
keep his position? Adrian Peterson, running back for the Minnesota Vikings, suffered a
torn anterior cruciate ligament during the 2011/12 season. While Peterson had an All-Star
performance this 2012/13 season, could it have been better if he had been able to
rehabilitate sooner from his tear? When time and performance is money in the arena of
professional athletics, all of these questions and possibilities must be addressed.
There are also the athletes who illegally use performance enhancing drugs and
cost their teams, sponsors, and themselves thousands of dollars. Would these players
make the same decision had they known the future outcome? In recent news, Lance
Armstrong revealed that he used performance enhancements during his reign of Tour de’
France victories. Due to his usage, Armstrong was stripped of his titles, banned from
competition, released of his 75 million dollar endorsement contract, and forced to step
down from the Livestrong Cancer Charity (Litke, 2013). When it comes to making
decisions about performance enhancement use, athletes need to understand the magnitude
of their decisions.
Biomedical study has quickly progressed since “Y.C. Fung played an important
role in the establishment of biomechanics as a modern, rigorous discipline, primarily
through the publication of an influential series of books on biomechanics” (Ethier, 2007,
p. 13). Biomechanics, bioengineering, genetic engineering, tissue engineering, and many
other studies have contributed greatly to the medical world, as well as the professional

BIOMEDICAL ADVANCEMENTS

10

world of sports. There have been such contributions as injury repair mechanisms,
performance enhancement, and even mechanical assistance through prosthetics.
Injury Repair Mechanisms and Methodologies
Injuries are the nemesis of athletes and therefore endless time, funding, and
research is devoted to injury repair and rehabilitation methods. The more quickly an
athlete can get back to work the better, and with the intensity of sports today, injuries
happen often. Many new techniques and methods are on the horizon for athletic injury
recovery.
Platelet Rich Plasma (PRP) Injection
Platelet Rich Plasma Injection (PRP) has been used in operating rooms for
decades to assist in the healing process of wounds or in certain surgery operations, such
as Spinal Fusion Surgery (Mishra et al., 2009, p.113). PRP is a dense concentration of
platelet cells, originating from the blood, and separated by a centrifuge. Platelet cells
from the blood have growth factors which are essential for the natural physiological
healing process. A growth factor is usually a steroid hormone, or a protein, which acts as
a signal within the body between cells to stimulate cellular growth (Tymoczko, 2013,
p.260). When PRP is injected into afflicted areas, the increase in growth factor stimulates
increased cellular response and therefore healing.
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Fig. 1. Photomicrograph of PRP. Note high concentration of platelets.
Mishra, A. , Woodall, J. , & Vieira, A. (2009). Treatment of tendon and muscle using platelet-rich plasma.
Clin Sports Med, 28(1), 113-125.

Platelet Rich Plasma Injection is a method sourced from the patient seeking
treatment. The patient’s blood is drawn, usually from the median cubital vein of the arm,
and the blood is placed in a centrifuge. The centrifuge spins the blood at high speed to
separate it into leukocytes, erythrocytes, blood plasma, and platelets. The platelet layer is
obtained and then injected into the injured area. Sometimes, the PRP injection is
supplemented with an activating agent of either thrombin or calcium chloride. These
activating agents serve to catalyze the healing process by acting like coagulant factor
enzymes in the injured area (Mishra et al., 2009, p.116).
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Fig. 2. The basic mechanisms for preparing PRP involve (A) withdrawal of the patient’s peripheral blood
and (B) centrifugation to obtain a concentration of platelets and cytokines. (C) The centrifuged product is
stratified into 3 layers.
Lopez-Vidriero, E. , Goulding, K. , Simon, D. , Sanchez, M. , & Johnson, D. (2010). The use of plateletrich plasma in arthroscopy and sports medicine: Optimizing the healing environment.
Arthroscopy, 26(2), 269-278.

While originally PRP was used in operating rooms for surgical recovery,
innovative techniques and advancements in this method have led to its use in the
orthopedic department of sports related injuries. Platelet Rich Plasma Injections have
begun to be used in Achilles tendonitis, Rotator Cuff tendonitis, “Tennis Elbow,” and
Patellar Tendonitis. Tendonitis is professionally stated as “a tendon injury resulting from
repetitive mechanical load with a subsequent inflammatory response” (Almekinders,
1998).
Achilles tendinitis is a common injury in sports strictly focused around running,
such as track, marathons, and cross-country. This injury is the result of a microscopic tear
in the Achilles tendon, which if not treated immediately, can progress into a macroscopic
tear requiring surgical repair (Almekinders,1998). When a microscopic tear is present,
PRP injection is inserted into the torn region of the Achilles tendon and thus stimulating
increased growth factor to the area. Commonly, Achilles tendinitis recovery time is
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between 6-8 weeks with ice, rest, and compression; however, with PRP, studies show a
50% reduction in recovery time to three to four weeks (Lopez-Vidriero, 2009, p.275).
Rotator cuff tendonitis and “Tennis Elbow”, otherwise known as elbow
tendonosis, can be common injuries of baseball, tennis, golf, volleyball, swimming, or
other sports with repetitive throwing, swinging of the arm, or “flicking” of the wrist.
Elbow tendonosis is caused by small tears in the tendons that attach the forearm muscles
to the arm bone at the elbow joint (Lopez-Vidriero, 2009, p.273). Rotator cuff tendonitis
occurs when there is inflammation of the rotator cuff tendons and the bursa that
surrounds these tendons. PRP injection can reduce the recovery process by as much as
50% in these common injuries as well with insertion into the torn tendon area (LopezVidriero, 2009, p.273).

Fig. 3. Injection of PRP for chronic elbow tendinosis.
Mishra, A. , Woodall, J. , & Vieira, A. (2009). Treatment of tendon and muscle using platelet-rich plasma.
Clin Sports Med, 28(1), 113-125.

Patellar tendonitis is a common injury to the knee area in athletics with excessive
jumping. Basketball, volleyball, track and field jumpers, and sometimes football players
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can be victims of Patellar tendonitis. This injury is brought on by inflammation in the
inferior patellar region (Almekinders, 1998). Prolonged use can then result in tears to the
patellar tendon. Some studies show that stiff ankle movement and ankle sprains
contribute to patellar tendonitis (Lopez-Vidriero, 2009, p.274).
Frequency Specific Microcurrent
Frequency Specific Microcurrent is a rapidly developing process to treat nerve or
muscle pain, due to damaged tissue or muscles. Cells in the human body produce current
in milliamps, while microcurrent is current on the order of 1/1,000,000 of an amp
(Webster, 2010, p.265). “Each cell, tissue and organ has an ideal resonant frequency that
coordinates its activities” (Oshman, 2011). Specific frequencies induce specific effects
for different physiological components of the human body. Where nerves might have an
ideal resonant frequency, muscle tissues of the ankle might have another. While
physioelectric therapy has been around since the late 1960s and early 1970s, it has not
been until recent discoveries that specific frequencies are used for different muscle,
tissue, and nerve groups within the body (Webster, 2010, p.269).
When microcurrent is passed through tissue at its specific resonance frequency,
the ATP production within the tissue cells is increased. With an increase in the basic
physiological energy unit, the physiological processes greatly increase in rate and
production. Cell formation increases, which, in turn, assists in rapid healing processes.
Protein synthesis and intracellular waste removal also increases, which add to the
increased healing rate (McMakin, 2003, p.146). By compression, strain, or stretching,
tissues or muscles can become torn and then inflamed. Inflammation and tearing alters
the specific resonant frequency of the tissues and muscles (McMakin, 2003, p.143).
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When microcurrent is passed through the inflicted area at the correct frequency, the
inflicted tissue and/or muscles can be resynchronized to their optimal resonant frequency.
This instantly increases the ATP production and healing processes as stated before
(Curtis et al., 2010, p.2).
Frequency specific microcurrent can be used in multiple areas of injury that
would be useful in athletics. It can be used as a post-op treatment for ligament, tendon
and scar tissue repair, or it can be used as a primary source of injury treatment for disc
pain, back or lumbar injury, strains, and tendinitis. A common injury to almost all sports
is lumbar pain of some sort. With the many biomechanical stresses and strains of
weightlifting and competition, lumbar and back injury is fairly common. A common
cause of this pain is myofascial trigger points (MTrPs). Depending upon the location of
the MTrPs, the back pain can be in the vertical cervical, horizontal rectus abdominus, or
gluteus medias/lumbar hip region (Curtis et al., 2010, p.6). “Myofascial pain can be
severe and debilitating, and can cause restrictions in normal biomechanical joint function,
impairment of neurological function, and impairment of circulation and lymphatic flow”
(Long et al., 1996, p.50). As an athlete this kind of injury can be sidelining for weeks, but
more often than not, months.
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Fig. 4. Subject position for FSM treatment.
Curtis, D. , Fallows, S. , Morris, M. , & McMakin, C. (2010). The efficacy of frequency specific
microcurrent therapy on delayed onset muscle soreness. J Bodyw Mov Ther, 14(3), 272-279.
With FSM, a back injury, as described earlier, can be rehabilitated to full health
very quickly by the body’s naturally healing techniques after the stimulation. Treatments
consist of a 30-40 minute session of low amperage microcurrent through the low back
twice a week for four weeks. In a study of 138 patients, all of which with pain ratings 6-8
on a scale of 10 with 10 being the most painful, 127 patients were reported with pain
ratings 0-2 after the four-week session (McMakin, 2003, p.149). The Frequency Specific
Microcurrent is capable of returning athletes to the field faster than traditional methods of
recovery for chronic low back myofascial pain and other similar injuries.
Biodegradable Silk Matrix for Anterior Cruciate Ligament (ACL)
The tearing of the anterior cruciate ligament (ACL) in the knee, unfortunately is a
common injury in athletics. This recovery must be executed through the use of
arthroscopic surgery and, contrary to common diction, the ligament can not be repaired,
but must be replaced. There are two methods consistently used to replace the torn
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ligament: autograph, which is the grafting of another ligament from the patient’s own
body, or allograft, which is the grafting of a ligament from a donor’s body (Hoehn, 2011,
p.691). The most common ligaments used to replace the native anterior cruciate ligament
are the hamstring tendon and the patellar tendon. Hamstring grafts are accomplished by
braiding together the hamstring semitendinosus tendon with an accessory adductor
tendon, and then attaching to the tibia and femur with screws (Hoehn, 2010, p.692). The
patellar graft is completed by removing the inner two-thirds of the patellar tendon and
attaching it to the tibia and femur with screws as well (Hoehn, 2010, p.692). It was not
until recent biomaterial advances that synthetic poly-silk fibers have been used for
anterior cruciate ligament repair.
With so many injuries to the anterior cruciate ligament, and the limited clinical
options available to repair the ligament, innovation is necessary to help the recovery
process. The necessity to quickly return full range of motion and full force capacity on
the ligament has led to engineering solutions with biomaterials. ACL tears most
commonly result in agonizing pain, discomfort, and little to no mobility. These
conditions prohibit participation in sports or exercise of any kind for extended periods of
time by current recovery rates (Lu, 2005, p.4808). The previously described methods of
recovery have tendencies to form tendinitis due to the poor healing qualities of both
hamstring and patellar tendons. However, silk-fiber matrices can be a suitable
replacement for ligament replacement. The silk matrix is designed and tissue engineered
to be equitable to the native ACL in mechanical properties, including fatigue. In order to
mirror the mechanical properties, a rope design is used with the silk fibers. Costello’s
equation for three stranded ropes was used to derive a multi-leveled silk fiber matrix that
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could be equitable to the stress-strain curve of human anterior cruciate ligaments
(Altman, 2002, p.4132).

Fig. 5. Schematic of an ACL 6-cord matrix hierarchy.
Altman, G. , Kaplan, D. , Horan, R. , Martin, I. , Moreau, J. , et al. (2002). Silk matrix for tissue engineered
anterior cruciate ligaments. Biomaterials, 23(20), 4131-4141.

The matrix of the silk polymer strands is designed such that the native human
cells local to the artificial ligament can grow into the matrices. This design significantly
increases the capability to mirror the natural knee stiffness, yield point, and elongation at
break. The actual cells that can physiologically attach to the artificial ligament are the
bone marrow stromal cells. Recent tests have returned data showing silk fiber ligaments
enduring three million cycles of stress and strain before failure (Altman, 2002, p.4138).
These results show promise for biomaterial replacement of ACL tears.
The exchange from human hamstring or patellar tendon to silk fiber replacement
will result in significant recovery time decreases for anterior cruciate ligament tears.
Early data has shown a three month recovery period with silk fibers in comparison to the
standard six month recovery with common methods. A 50% decrease in recovery time
could salvage a season that could have been lost for an athlete suffering from ACL tear.
Performance Enhancement Mechanisms and Methodologies
In the very competitive world of sports today, the athlete who is faster, stronger,
and better conditioned is king. Natural means of increasing strength through weight
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training or conditioning are no longer fast enough to keep pace with the most competitive
players. As biomedical knowledge assimilates into the sporting world, methods for
enhancing performance medically, and even genetically, rapidly take form. The legality
of these methods have yet to be determined in some cases, however athletes need to be
aware of what enhancement methods are circulating or on the horizon.
Erythropoietin Gene Therapy
While the use of Erythropoietin (EPO) is not relatively new, the gene therapy
mechanisms to make its use more efficient and difficult to trace are a recent
breakthrough. EPO is a glycoprotein hormone that sends signals to the red blood cells.
When these signals are sent from the EPO glycoproteins to the red blood cells, the red
blood cells increase production (Tymoczko, 2013, p.243). By adding an abundance of
EPO to the human biochemistry, an abundance of red blood cells are produced. An
increase in red blood cells allows for more oxygen to be carried throughout the body, and
thus, physical endurance increases, while fatigue decreases (Indiveri, 2002, p.5).
The use of EPO in the athletic arena is one form of blood doping. The oxygen
delivery system of the human body including lung function, heart stroke volume, and
vascularization are all limiting factors to endurance and well as the performance of
muscle activity. Therefore, when an athlete can increase the efficiency and production of
their oxygen delivery system, their performance can also increase (Tymoczko, 2013,
p.240). This is why EPO has been commonly found in such endurance sports as biathlon,
triathlon, distance running, and especially cycling.
In the 1990s, EPO increase in the body was conducted through blood transfusions.
The patient would have blood drawn, allow the body to naturally produce red blood cells
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back to the natural limit, and then inject the drawn blood back into the body to increase
the EPO and red blood cell count. In the early 2000s this method became traceable by
urine test, and drugs designed to increase EPO count were produced to counter the testing
method. However, this orally consumed EPO initiator became traceable through blood
testing methods (Ethier, 2007, p.150).
The newest method to increase red blood cell and EPO production is put into the
body through gene therapy methods. The gene for EPO hormone conductors is isolated in
bone marrow. Once isolated, the gene is replicated and attached to a DNA vector where it
is injected back into the human body (Gauglitz, 2011, p.1471). The vector helps the gene
penetrate into the human cells and the gene is then coded into the cell’s DNA. The
natural DNA replication methods of the cells take over and produce increased amounts of
the newly injected EPO conductors, thus EPO levels increase and, with it, red blood cell
count (Indiveri, 2002, p.7).
Insulin-like Growth Factor-1 (IGF-1) Gene Therapy
In the human body, especially during adolescence, the insulin-like growth factor 1
(IGF-1) hormone works to help the growth development of the body. The insulin-like
growth factor is a hormone coded by the IGF-1 gene and when the quantity is increased
in a developed adult, it has anabolic effects (Tymoczko, 2013, p.514). Like EPO doping,
IGF-1 has been in circulation in the athletic community for some time. However, recent
developments in gene therapy have increased its untraceability.
The human body releases growth hormones into the blood, which then activates
the release of IGF-1 hormone. The IGF-1 hormone stimulates the systemic growth in the
body and almost all cell types, especially skeletal muscle cells, which attributes to its use
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in athletes. Much like insulin, IGF-1 hormone also regulates the growth of those cells by
its own concentration levels (Tymoczko, 2013, p.372). The significant stimulation of
skeletal muscle growth by IGF-1 is what is so appealing to athletics, as strength is
important to success in most competitive environments.
Until recently, IGF-1 hormone had to be ingested orally, and consequently could
be traced in blood tests. With the advancing developments of gene therapy, primarily for
disease and cancer therapeutics, IGF-1 gene therapy methods have been created. IGF-1
has been significantly used in the attempt to heal epidermal wounds and, therefore,
multiple gene implantation techniques have been created such as intracutaneous injection
of DNA, liposomes, a gene gun or electroporation (Gauglitz, 2011, p.1743). “Gene gun is
a technique used to penetrate the cellular membrane with which the gold or tungstencoated particles carrying DNA plasmids are propelled into skin cells” (Gauglitz, 2011,
p.1743). With the IGF-1 gene coded into the DNA plasmids, the IGF-1 gene is
successfully inserted into the human DNA coding within the cell. The cells natural
replication process then produces increased quantities of IGF-1 hormone in the body
(LeRoith, 2007, p.303).

Fig. 6. The actions of IGF1.

BIOMEDICAL ADVANCEMENTS

22

LeRoith, D. , Yakar, S. , & GROUP, N. (2007). Mechanisms of disease: Metabolic effects of growth
hormone and insulin-like growth factor 1. Nature Clinical Practice Endocrinology & Metabolism,
3(3), 302-310.

When this growth factor protein was given to mice in studies, results have shown
that the bulkier muscles of the mice contract much more easily and the muscle rebuild is
faster (Wolfram, 2007, p.3). Therefore, in the instance of strength training, athletes with
increased IGF-1 would be able to lift more weight easier and then rebuild those muscle
fibers faster, thus increasing strength gains at a much faster rate.
PPAR-Delta and GW1516 Metabolic Rate Accelerator
One of the newest performance enhancing discoveries under development and
testing is the PPAR-delta modulator compound, known as GW1515 or GW501516. This
modulator compound essentially can activate PPAR-delta and AMP-activated protein
kinase. The activation of these two proteins by GW1516 is the same activation that
occurs during the metabolic activity from exercise (Wei, 2003, p.9117). Essentially
GW1516 tells the body that it is exercising even though it is not.
Through these activation pathways a number of athletically beneficial results
occur in the body. From the presence of GW1516, the body can increase its consumption
of glucose in skeletal muscle cells, as well as, activate more gene expression of those
skeletal muscle tissues (Wei, 2003, p.9118). The body also can express genes that code
for the utilization of lipids as fuel sources at a higher rate (Wolfram, 2007, p.580). This
accelerated gene expression changes the body’s metabolism to favor the burning of lipids
for energy within the body instead of proteins for muscle or carbohydrates. Essentially,
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the body would burn fat stores while increasing muscle cell production, allowing users to
become more lean and stronger simultaneously.

Fig. 7. Compound 7 (magenta) docked into the active site of the
PPARä receptor crystallized with GW2433.
Sauerberg, P. , Olsen, G. , Jeppesen, L. , Mogensen, J. , Pettersson, I. , et al. (2007). Identification and
synthesis of a novel selective partial pparδ agonist with full efficacy on lipid metabolism in vitro
and in vivo. J. Med. Chem, 50(7), 1495-1503.

Many studies on the GW1516 modulator compound have been conducted on mice
with relatively astonishing results. In a study in which mice were fed a high fat diet, the
GW1516 modulator allowed mice to resist lipid mass accumulation (Sauerberg, 2007,
p.1497). These same results in athletes would prove to be astounding in performance
modification. Currently, the GW1516 compound modulator is available through oral
consumption (Wei, 2003, p.9119). Because of this, the presence of this modulator can be
tested for via blood sample if there is suspicion of ergogenic use.
Mechanical Assistance Technology
Biomedical application to modern technology has resulted in a variety of
advanced prosthetics and mechanical assistance devices capable of athletic endeavors.
Whether it is an athlete who has undergone a tragic accident or someone born with the
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necessity for physical assistance, each person should have adequate equipment to strive
for their athletic goals and aspirations. Some of the newest prosthetic devices available
can allow these aspirations to be achieved.
Össur Flex-Foot Cheetah
Whether by birth or by a traumatic event, some athletes need transtibial or
transfemoral prosthetics for assistance. Normal prosthetics can hinder the full range of
motion a normal appendage would be capable of, or they can be mechanically unfit for
the stresses, strains, and loads of athletic recreation (Cheetah, 2013). The Össur Flex-Foot
Cheetah is a top of the line prosthetic built for athletic endeavors.
The Flex-Foot Cheetah, which is made by Össur, is a carbon fiber transtibial and
transfemoral blade custom designed for sporting activities. The blade is only 18.1 ounces
in weight and can be used by patients up to 335 pounds (Cheetah, 2013). Each blade is
custom built for its patient based on impact levels. For someone who is very athletic and
looking to compete in track and field, or a sport with high intensity running, the Impact
Level 4: Sport/Extreme level would be used. This level is “designed to enable high
impact sports and activities with repeated extreme level of impact on the foot” (Cheetah,
2013).
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Fig. 8. Carbon fiber Flex-Foot Cheetah blade.
Cheetah. (2013). Ossur. Retrieved from: http://www.ossur.com/?pageid=13462

One of the breakthrough ideas about the Flex-Foot Cheetah is its patented energy
storage and release system. The blade functions closely to the characteristics of a spring,
taking kinetic energy, storing it as potential energy, and then releasing it as kinetic energy
once again. The second breakthrough idea contributing the ingenuity of the Cheetah is the
vertical shock absorption. The Flex-Foot Cheetah’s ability to absorb shock allows the
natural limb, in connection to the prosthetic, to be safe as well as contributing to a more
natural gait (Cheetah, 2013).
In a study, the Flex-Foot Cheetah was able to produce a mean running speed of
6.84m/s. In that same study, the mean muscle power generated by the hip flexor of the
leg with the Cheetah was 1,058 W, and the moment knee extensor was 170N*m. This
study showed how the Flex-Foot Cheetah can give its users more natural gait with
competitive running power and speed (Buckley, 2000, p.354).
The most influential owner of the Flex-Foot Cheetah to date is South African
Olympic runner, Oscar Pistorius. Pistorius uses two Flex-Foot Cheetahs and was able to
produce sprinting times that qualified him into being the first Paralympian to compete in
the Olympic Games. Because of Pistorius’ professional running technique, the
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capabilities of the Flex-Foot Cheetah were maximized to Olympic competition quality.
The Flex-Foot Cheetah can take athletes in need past walking to a competitive state of
sprinting and enjoying sports.
Ottobock Genium
In most sports, the knee is a very important joint and allows the functions and
actions necessary to participate at a high level. The knee is arguably the most intricate
and complex joint in the body. The knee is also very vulnerable due to the stresses and
pressure loads placed upon it. During the walk cycle, knees can support up to 1.5 times
the weight of the body (Ethier, 2007, p.389). Therefore, if an athlete does not have the
natural anatomical knee, it is critical that the prosthesis used be constructed with fine
detail.

Fig. 9. Ottobock Genium knee joint microprocessor controlled.
C-Leg Microprocessor Prosthetic Knee. (2013). Ottobock. Retrieved from:
http://www.ottobockknees.com/knee-family/c-leg-microprocessor-prosthetic-knee/
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The Genium by Ottobock is a prosthetic knee joint that is control by a
microprocessor. The Genium’s complex sensory system allows the patients gait to be
mimicked to that of a natural gait. This prosthetic keeps a constant 4 degrees of flexion at
all times during walking, to allow the Heel Strike phase to occur rapidly and put the foot
on the ground more evenly. Genium has a gyroscope and a two axis accelerometer which
continuously sample the environment for the safest release and locking mechanisms (CLeg, 2013).
During the Swing Phase of walking or running, the foot must clear the ground
before Heel Strike in order to avoid stumbles and falls. In clinical study, the Genium has
shown a maintained joint angle of 63.8 degrees of flexion at any speed of gait in order to
avoid this problem (Bellman, 2012). The required flexion angle of the knee joint during
Swing Phase in order to avoid stumbles and falls is between 60 and 65 degrees (Bellman,
2012). Therefore, the Genium knee is perfectly designed to keep users away from
possible falls, due to poor walking mechanics.

Fig. 10. Mean values of maximum knee flexion angles on the prosthetic
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side at swing phase during level ground walking at 3 velocities.
Abbreviations: deg, degree; v, velocity (m/s).
Bellmann, M. , Schmalz, T. , Ludwigs, E. , Blumentritt, S. , & W B SAUNDERS CO-ELSEVIER, I.
(2012). Immediate effects of a new microprocessor-controlled prosthetic knee joint: A
comparative biomechanicall evaluation. Archives of Physical Medicine and Rehabilitation, 93(3),
541-549.

The Ottobock Genium is a perfect knee replacement for athletes looking to
seriously return or begin play. Athletes using Genium would be able to correctly pivot,
accelerate, decelerate, and change directions safely, and correctly, due to its continuously
functioning microprocessor and locking system. In another study of biomechanic
function, ‘‘the Genium demonstrated immediate biomechanical advantages during
various daily ambulatory activities, which may lead to an increase in range and diversity
of activity of people with above-knee amputations’’ (Bellmann, 2012, p.541).
Design
Advances in computer science, biomedical engineering, and other technical fields
continue to revolutionize athletics as well. The most effective injury prevention solutions,
performance enhancement techniques, and mechanical assistance devices are useless if
the information never reaches the athletes in need. Athletes need a means by which they
can tap into a source for the cutting edge information. In a world driven by social media,
a website for the latest developments in biomedical, genetic, and prosthetic studies
applicable to athletics would be very beneficial. In theory, this website could then be
transformed into a Facebook page, Twitter account, or any other social media database
for circulating the usable information.
Running the Program
The program runs in Java, therefore Java must be installed on the user’s computer
in order to run properly. To install Java:
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1. Open Internet Browser and go to Java.com
2. Click on the free Java download selection
3. Select ‘Agree and Begin Download’ selection
4. When prompted select ‘Run’ to initiate download
5. When Java Setup window opens, select ‘Install’
After completely these steps, Java has been successfully installed on the computer and
the program can be run by simply double-clicking the Jar file icon on the desktop, if the
file has been saved to desktop. In the occurrence that the program does not run, the JRE
needs to be installed and this can be completely by simply going back to Java.com for the
free download.
Java Swing
This design is a very rudimentary prototype of the initial website idea in the form
of a local program. The application programming interface (API) used for this design is
Java Swing. Java Swing is an API that specializes in providing easy to manipulate
graphical user interfaces (GPU) (The Java Tutorials, 2013).
Main.java
When a Java program is started, the “main” method is called. This beginning of
my program is in the Main class. Here, a new MainFrame is created which builds the
graphical user interface from the Swing API. This code creates a new JFrame which will
display on the screen. A JFrame “constructs a new frame that is initially invisible” (Java
Platform Standard Edition 7, 2013). The JFrame is basically its own window for the
program to run in. Once a JFrame is created, a JPanel is added to it. The JPanel
essentially holds the components (buttons, lists, text, ect.) that is displayed on the screen.
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MainFrame.java
The next code file is the MainFrame.java file. Next the public class MainFrame
extends JFrame. This creates a new MainView and adds the view to this JFrame. The
MainView is the main JPanel that will hold all the components that make up the program.
The MainFrame constructor will now be called whenever the “new MainFrame” is used.
The JFrame is told to close when the ‘x’ button is clicked on the window by using the
setDefaultCloseOperation. Because of the rudimentary style of the program, the JFrame
will be the only window open and therefore the only necessary window to close to close
the program.
From there, the MainView is constructed and is added to the JFrame’s Content
Pane. The command pack( ) is a method provided in the JFrame class (Java Platform
Standard Edition 7, 2013). Essentially this code tells the JFrame to make its size just big
enough for the JFrame’s components to be displayed at each of their preferred sizes. A
specific component can set its own preferred size when it is created. Lastly,
setVisble(true) is written to display the JFrame and all components that fill it up.
MainView.java
The MainView has multiple components initially imported into it (JComboBox,
JLabel, JPanel, JScrollPane, ect.). The MainView extends JPanel, similarly to
MainFrame. In other words, it is a JPanel that has additional properties and components
that I add. In MainFrame.java, I only added a MainView to the MainFrame (it extends
JFrame), so this JPanel will fill up the window that is part of the MainFrame. Instance
variables for the sidebar, work space, ‘sport’ combo box, ‘types’ combo box, and doc
viewer are created to be implemented into those functions in the program. Integer
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variables are created for the individual categories in the program (Overview, Baseball,
Football, Track, Injury, Performance, and Mechanical) because they are constants that are
used to coordinate with the indexes of each sport and enhancement type. Strings are
created for the actual text names of the program categories as well as constants that are
strings for each HTML file’s path in the program.
Then, the setLayout method is called. This will change the layout of the
MainView to a BorderLayout. A BorderLayout is a type of LayoutManager (Java
Platform Standard Edition 7, 2013). LayoutManagers instruct the JPanel where to put the
component that is added (Java Platform Standard Edition 7, 2013). I’m using a
BorderLayout because it can be used to make a component fill the remaining space of the
JPanel it is applied to. In this case, the MainView is split into two sections: a “side bar”
on the left, and a “work space” on the right. The side bar should only take up as much
space as it asks for while the work space will take up the rest of the space. A simple add
method is used to add the SideBar, WorkSpace, SportComboBox, TypeComboBox, and
DocPane to the MainView. The side bar is a JPanel so that its components can be altered.
Using setBackground and setPreferredSize, the side bar color is changed to a new color
using the hexadecimal value of a specific color and the dimensions of the side bar are set
respectively.
The work space is then added to the MainView and its components are altered
using the same systematic approach as the side bar. Using JLabel and JComboBox, the
‘sport’ label is added to the MainView. A JLabel is a component that displays text (Java
Platform Standard Edition 7, 2013). A JComboBox is a component that will show a list
when clicked on and then when the user selects from the list, the original text will update
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(Java Platform Standard Edition 7, 2013). The JComboBox is created and added to the
side bar.
Next, an ItemListener is added to the JComboBox, where an ItemListener is an
interface that has the method itemStateChanged (Java Platform Standard Edition 7,
2013). The JComboBox calls this method whenever an item is selected from its list. The
ItemListener “listens” for this selection and signals the itemStateChanged method. Every
time an item is selected, another item is deselected, and therefore, itemStateChanged is
actually called twice. I only want the comboBoxItemSelected method to be called once,
so I check if an item is selected and ignore when it is deselected using a simple if
statement. The same systematic approach and modifications are taken for the other
JComboBox in the program.
In this program, a document viewer is necessary, therefore I created the
addDocPane method which creates a new JEditorPane. A JEditorPane is a component
that takes in a file to display (Java Platform Standard Edition 7, 2013). In this program, I
have a list of HTML files to display. The JEditorPane is kept form editing in the running
program and the runtime error exception is thrown if a file is not found using two code
sources from the Java code list (Java Platform Stadard Edition 7, 2013). The JEditorPane
is added to a JScrollPane. A JScrollPane is a component that takes in a single component
and adds a scroll bar to it (Java Platform Standard Edition 7, 2013). This allows the
JEditorPane to be larger than the screen since we can scroll to see the rest of it. The
JEditorPane will be updated to display another HTML file whenever one of the
JComboBoxes are selected. This is done by using the ItemListener that we added to the
JComboBoxes. The file that is shown in the JEditorPane is determined by the newly
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selected values from the JComboBoxes. Switch cases are used to create and return a new
file from the path in the baseball, football, or track arrays. It is possible that the program
looks to create a file and for whatever reason the URL is invalid. In this case, an
exception will be thrown. Since a program crash is not desired, a try catch statement is
used to intercept the exception and keep the program from crashing (Java Platform
Standard Edition 7, 2013).

Conclusion
All in all, this local program made with Java Swing allows us to view different
HTML documents. These documents are selected by the user interacting with the
graphical user interface. The documents contain information about some of the latest
advances biomedically, genetically, and mechanically that are applicable to athletes and
the sports listed in the program. This rudimentary prototype is the beginnings of an
information source for athletes to become knowledgeable about the advantages of
technology in the athletic world.
Program Code
Main.java
package com.russell.tech;
public class Main {
/*
* Starting point of the program.
*/
public static void main(String[] args) {
/*
* Creates a new "JFrame" which will display on the
screen.
*/
new MainFrame();
}
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}

MainFrame.java
package com.russell.tech;
import javax.swing.JFrame;
/*
* Creates a new MainView and adds the view to this JFrame.
*/
public class MainFrame extends JFrame {
/*
* MainFrame constructor is called whenever "new
MainFrame()" is used.
*/
public MainFrame() {
/*
* Tell the JFrame to close when the 'x' button is
clicked on the window.
*/
setDefaultCloseOperation(DISPOSE_ON_CLOSE);
// Construct the MainView
MainView view = new MainView();
// Add the MainView to this JFrame's Content Pane.
getContentPane().add(view);
/*
* Determine the size of the JFrame.
*/
pack();
// Display the JFrame and all components that fill it
up.
setVisible(true);
}
}

MainView.java
package com.russell.tech;
import java.awt.BorderLayout;
import java.awt.Color;
import java.awt.Dimension;
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import
import
import
import

java.awt.event.ItemEvent;
java.awt.event.ItemListener;
java.io.IOException;
java.net.URL;

import
import
import
import
import

javax.swing.JComboBox;
javax.swing.JEditorPane;
javax.swing.JLabel;
javax.swing.JPanel;
javax.swing.JScrollPane;

35

public class MainView extends JPanel {
/*
* Instance variables
*/
private JPanel sideBar;
private JPanel workSpace;
private JComboBox sportComboBox;
private JComboBox typesComboBox;
private JEditorPane docViewer;
/*
* Constants that coordinate with the indexes of each sport
and enhancement type
*/
public static final int SPORT_OVERVIEW = 0;
public static final int SPORT_BASEBALL = 1;
public static final int SPORT_FOOTBALL = 2;
public static final int SPORT_TRACK = 3;
public static final int TYPE_INJURY = 0;
public static final int TYPE_PERFORMANCE = 1;
public static final int TYPE_MECHANICAL = 2;
private static final String[] sports = { "Overview",
"Baseball", "Football", "Track and Field" };
private static final String[] types = { "Injury",
"Performance", "Mechanical" };
/*
* Constants that are strings for each file's path.
*/
private static final String[] baseballFiles = {
"/res/PlateletRichPlasma/doc.html", "/res/Insulin/doc.html",
"/res/OttobockGenium/doc.html" };
private static final String[] footballFiles = {
"/res/BiodegradableSilkMatrixforAnteriorCruciateLigament/doc.html
", "/res/PPAR/doc.html",
"/res/OttobockGenium/doc.html" };
private static final String[] trackFiles = {
"/res/FrequencySpecificMicrocurrent/doc.html",
"/res/ErythropoietinGeneTherapy.html",
"/res/ssurFlex/doc.html" };
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private static final String overviewFile =
"/res/Overview.html";
/*
* The MainView constructor.
*/
public MainView() {
/*
* Change the layout of the MainView to a
BorderLayout.
*/
setLayout(new BorderLayout());
/*
* Add components to the MainView.
*/
addSideBar();
addWorkSpace();
addSportComboBox();
addTypeComboBox();
addDocPane();
}
/*
* Adds the "side bar" JPanel to the MainView.
*/
private void addSideBar() {
// Construct a JPanel for the side bar
sideBar = new JPanel();
/*
* Change the background color of the side bar.
*/
sideBar.setBackground(new Color(0xE5E5E5));
/*
* Set the side bar to request itself to be shown at a
specific size.
*/
sideBar.setPreferredSize(new Dimension(300, 900));
/*
* Add the side bar to the MainView. The second
argument (BorderLayout.LINE_START) tells the
* MainView's LayoutManager that we set earlier, a
BorderLayout, to add the side bar to the
* left side of the panel. It will allow the side bar
to take up as much space as it
* requested (300 px x 900 px).
*/
add(sideBar, BorderLayout.LINE_START);
}

BIOMEDICAL ADVANCEMENTS

37

/*
* Adds the "work space" JPanel to the MainView.
*/
private void addWorkSpace() {
// Construct a JPanel for the work space
workSpace = new JPanel();
/*
* Sets the layout just as I did before in the
MainView constructor. The work space also
* uses a BorderLayout so the document viewer
component can be told to fill up all the space
* available.
*/
workSpace.setLayout(new BorderLayout());
workSpace.setBackground(new Color(0xFFFFFF));
/*
* Add the work space to the MainView. The second
argument (BorderLayout.CENTER) tells the
* MainView's LayoutManager to add the work space to
the center of the panel. The
* BorderLayout tells the center component to fill all
remaining space.
*/
add(workSpace, BorderLayout.CENTER);
}
/*
* Adds the "sport" JLabel and JComboBox to the MainView.
*/
private void addSportComboBox() {
/*
* Create and add a JLabel component to the side bar.
*/
JLabel label = new JLabel("Sport");
sideBar.add(label);
/*
* Create and add a JComboBox component to the side
bar.
*/
sportComboBox = new JComboBox(sports);
sideBar.add(sportComboBox);
/*
* Add an ItemListener to the JComboBox.
*/
sportComboBox.addItemListener(new ItemListener() {
@Override
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public void itemStateChanged(ItemEvent e) {
if (e.getStateChange() ==
ItemEvent.SELECTED)
comboBoxItemSelected();
}
});
}
/*
* Same as the addSportComboBox except that the label is
"Enhancement Type".
*/
private void addTypeComboBox() {
JLabel label = new JLabel("Enhancement Type");
sideBar.add(label);
typesComboBox = new JComboBox<String>(types);
sideBar.add(typesComboBox);
typesComboBox.addItemListener(new ItemListener() {
@Override
public void itemStateChanged(ItemEvent e) {
if (e.getStateChange() ==
ItemEvent.SELECTED)
comboBoxItemSelected();
}
});
}
/*
* Adds a component that will display the html documents.
*/
private void addDocPane() {
try {
/*
* Creates the document viewer which is a
JEditorPane.
*/
docViewer = new JEditorPane();
docViewer.setPage(loadFile(SPORT_OVERVIEW,
TYPE_INJURY));
// Tell the JEditorPane to not allow any editing
in the view.
docViewer.setEditable(false);
// Catch the runtime exception that is thrown if
a file is not found.
} catch (IOException e1) {
e1.printStackTrace();
}
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/*
* Create a JScrollPane and add the JEditorPane to it.
*/
JScrollPane p = new JScrollPane(docViewer);
workSpace.add(p, BorderLayout.CENTER);
}
/*
* This method is called whenever a JComboBox is selected.
*/
private void comboBoxItemSelected() {
// Get the index of the selected item.
int selectedSport = sportComboBox.getSelectedIndex();
int selectedType = typesComboBox.getSelectedIndex();
try {
/*
* Change the html file that is shown in the
document viewer.
*/
docViewer.setPage(loadFile(selectedSport,
selectedType));
} catch (IOException e) {
e.printStackTrace();
}
}
/*
* Loads the file appropriate file based on the sport and
type.
*/
private URL loadFile(int sport, int type) {
switch (sport) {
case SPORT_BASEBALL: // if sport equals
SPORT_BASEBALL
/*
* Creates and returns a new file from the
path in the baseball string array.
*/
return
getClass().getResource(baseballFiles[type]);
case SPORT_FOOTBALL:
return
getClass().getResource(footballFiles[type]);
case SPORT_TRACK:
return
getClass().getResource(trackFiles[type]);
}
return getClass().getResource(overviewFile);
}}
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Appendices

Appendix I

Upon opening the program, the ‘Start-Up page’ of the program with the ‘Overview’
document is viewable. The drop-down menus are located on the left of the ‘Information
Display Window.’
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Appendix II

The drop-down menu arrow for ‘Sport’ is selected and the selections are viewable and
available for selection. Those include: ‘Overview,’ ‘Baseball,’ ‘Football,’ and ‘Track and
Field.’
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Appendix III

The ‘Baseball’ selection is selected and ‘Injury’ is held in the ‘Enhancement Type’ dropdown menu. The information for an innovative injury repair mechanism applicable to
baseball is displayed.
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Appendix IV

The ‘Enhancement Type’ drop-down menu arrow is selected and the selections are
viewable and available for selection. Those include: ‘Injury,’ ‘Performance,’ and
‘Mechanical.’
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Appendix V

The ‘Performance’ selection is selected within the ‘Baseball’ file. The information for an
innovative performance enhancement mechanism applicable to baseball is displayed.
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Appendix VI

The ‘Mechanical’ selection is selected within the ‘Baseball’ file. The information for an
innovative prosthetic knee replacement device usable for baseball is displayed.
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Appendix VII

Within the ‘Mechanical’ page of the ‘Baseball’ file, the scrollbar on the right of the
‘Information Display Window’ is scrolled down and the rest of the page is displayed.
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